Patent · US Active

Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound

US9243010B2 · kind B2 · utility

1Cited by

5References

4Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Martin D. Eastgate · Titusville, US
Michael S. Bultman · Allendale, US
Ke Chen · Sichuan, CN
Dayne Dustan Fanfair · Plainsboro, US
Richard J. Fox · Kirkwood, US
Thomas E. La Cruz · New Brunswick, US
Boguslaw M. Mudryk · Plainsboro, US
Christina Ann Risatti · Princeton, US
James H. Simpson · Fryeburg, US
Maxime C. Soumeillant · Hamilton Square, US
Jonathan Clive Tripp · San Mateo, US
Yi Xiao · Fanwood, US

Key dates

Filing date	Oct 17, 2014
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Oct 28, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/6561
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A process for the preparation of the compound of Formula Iis set forth utilizing the starting compound 1and the acid chloride compound

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.